THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO and Quest Diagnostics formed a collaboration to research advanced diagnostics in the field of precision medicine. Initial clinical areas of focus include autism, oncology, neurology and women’s health.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
